1. "Steven Larson"
  2. "Nai-Kong Cheung"
Formats
  1. Journal Article (50)
  2. Meeting Abstract (47)
  3. Conference Paper (2)
  4. Book Section (1)
  5. Review (1)
Groups
  1. Alan and Sandra Gerry Metastasis and Tumor Ecosystems Center (101)
  2. GSK Faculty (101)
  3. Molecular Imaging and Therapy Service (101)
  4. Molecular Pharmacology and Chemistry Program Faculty (101)
  5. Neuroblastoma Service (101)
  6. Pediatrics, Department of (101)

More Groups

People
  1. Nai-Kong Cheung (101)
  2. Steven Larson (101)
  3. Pat Zanzonico (47)
  4. Kim Kramer (44)
  5. Brian Kushner (30)
  6. John Humm (30)

More People

Years
  1. 2023 (3)
  2. 2022 (11)
  3. 2021 (6)
  4. 2020 (7)
  5. 2019 (5)
  6. 2018 (5)

More Years

Publications
  1. Journal of Nuclear Medicine (20)
  2. Neuro-Oncology (10)
  3. Journal of Clinical Oncology (9)
  4. Pediatric Blood and Cancer (9)
  5. Nuclear Medicine and Biology (7)
  6. Cancer Research (4)

More Publications

Publishers
  1. Society of Nuclear Medicine (20)
  2. American Association for Cancer Research (10)
  3. Oxford University Press (10)
  4. American Society of Clinical Oncology (9)
  5. Wiley Periodicals, Inc (9)
  6. Elsevier Science Inc. (7)

More Publishers

Results (101)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Pretargeted radioimmunotherapy with (212)Pb-DOTA-based haptens in nude mice bearing established human-colorectal xenografts
    Meeting Abstract

    Vaughn, B.; Veach, D.; Vargas, D. B.; Punzalan, B.; Zanzonico, P.; Xu, H.; Guo, H. F.; Yang, G.; Ouerfelli, O.; Cheung, N. K.; more...
    Journal of Nuclear Medicine (2023)

    Fulltext@MSK | Save
  • Efficacy of HER2-targeted intraperitoneal (225)Ac α-pretargeted radioimmunotherapy for small-volume ovarian peritoneal carcinomatosis
    Journal Article

    Chung, S. K.; Vargas, D. B.; Chandler, C. S.; Katugampola, S.; Veach, D. R.; McDevitt, M. R.; Seo, S. H.; Vaughn, B. A.; Rinne, S. S.; Punzalan, B.; more...
    Journal of Nuclear Medicine (2023)

    Fulltext@MSK | Save
  • Engineering CAR-T cells for radiohapten capture in imaging and radioimmunotherapy applications
    Journal Article

    Kurtz, K.; Eibler, L.; Dacek, M. M.; Carter, L. M.; Veach, D. R.; Lovibond, S.; Reynaud, E.; Qureshy, S.; McDevitt, M. R.; Bourne, C.; more...
    Theranostics (2023)

    Fulltext@MSK | Save
  • Self-assembling and disassembling (SADA) domain is critical to the binding, and anti-tumor efficacy of GD2-SADA
    Meeting Abstract

    Santich, B. H.; Kjellev, S. L.; Cheal, S.; Wang, L.; Gillberg, M.; Vadlamudi, M.; Ouattara, A. A.; Liebenberg, N.; Larsen, L. F.; Veach, D. R.; more...
    Cancer Research (2022)

    Fulltext@MSK | Save
  • Establishment of efficacy of DOTA-based pretargeted radioimmunotherapy with a bivalent radiohapten for enhanced therapeutic indices
    Meeting Abstract

    Vaughn, B.; Veach, D.; Vargas, D. B.; Seo, S.; Punzalan, B.; Zanzonico, P.; Xu, H.; Guo, H. F.; Yang, G.; Ouerfelli, O.; more...
    Journal of Nuclear Medicine (2022)

    Fulltext@MSK | Save
  • Phase 1 study of intraventricular (131)I-omburtamab targeting B7H3 (CD276)-expressing CNS malignancies
    Meeting Abstract

    Modak, S.; Pandit Taskar, N.; Kushner, B.; Zanzonico, P.; Humm, J.; Donzelli, M.; Lewis, J.; Lyashchenko, S.; Chu, B.; Larson, S.; more...
    Pediatric Blood and Cancer (2022)

    Fulltext@MSK | Save
  • Characterization of a novel radiohapten capture system in car T cells for tracking in vivo and improving CAR T efficacy
    Meeting Abstract

    Kurtz, K.; Dacek, M.; Cheal, S.; Veach, D.; Qureshy, S.; Carter, L.; Eibler, L.; Verma, S.; McDevitt, M.; Punzalan, B.; more...
    Human Gene Therapy (2022)

    Fulltext@MSK | Save
  • A radiohapten capture system for CAR T cells that tracks them in vivo and improves efficacy
    Meeting Abstract

    Kurtz, K.; Eibler, L.; Dacek, M.; Carter, L.; Cheal, S.; Veach, D.; Qureshy, S.; Han, J.; Reynaud, E.; Verma, S.; more...
    European Journal of Cancer (2022)

    Fulltext@MSK | Save
  • Phase 1 study of intraventricular (131)I-omburtamab targeting B7H3 (CD276)-expressing CNS malignancies
    Journal Article

    Kramer, K.; Pandit-Taskar, N.; Kushner, B. H.; Zanzonico, P.; Humm, J. L.; Tomlinson, U.; Donzelli, M.; Wolden, S. L.; Haque, S.; Dunkel, I.; more...
    Journal of Hematology & Oncology (2022)

    Fulltext@MSK | Save
  • Long-term survival from a phase 1 doseescalation trial using convection-enhanced delivery (CED) of radioimmunotherapeutic (124)I-omburtamab for treatment of diffuse intrinsic pontine glioma (DIPG)
    Meeting Abstract

    Souweidane, M. M.; Kramer, K.; Pandit-Tasker, N.; Haque, S.; Zanzonico, P.; Carrasquillo, J.; Lyashchenko, S. K.; Thakur, S. B.; Khakoo, Y.; Dunkel, I. J.; more...
    Neuro-Oncology (2022)

    Fulltext@MSK | Save